Search
Search Results
##search.searchResults.foundPlural##
-
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1452PDF: 906HTML: 2211Response to reviewers comments: 180 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
841PDF: 486HTML: 1303 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1961PDF: 812HTML: 221 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9063PDF: 6057HTML: 87957Fig.1b: 185Fig.1c: 189Fig.2a: 177Fig.2b: 176Fig.4: 188Fig.2c: 184Fig.3: 182Tab.1: 228Tab.2: 207Tab.3: 189Tab.4: 221Fig1a: 182 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2579PDF: 862HTML: 17469Fig1 Caligaris: 172Fig.2 Caliga: 203 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1723PDF: 1163HTML: 246 -
-
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1117PDF: 487HTML: 233 -
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1266PDF: 601HTML: 1096 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2491PDF: 922HTML: 530 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1242PDF: 865HTML: 1116Coverletter: 192 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
775PDF: 586Suppl. Files: 123HTML: 91 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1194PDF: 1067HTML: 202 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3368PDF: 1280HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2218PDF: 964HTML: 1897 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1277PDF: 606HTML: 3078 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
478PDF: 243HTML: 79 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2866PDF: 1230HTML: 2698Figure 1: 172 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2083PDF: 1521HTML: 285 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3194PDF: 1580HTML: 259 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2099PDF: 486HTML: 129 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1563PDF: 772HTML: 1304 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1223PDF: 591HTML: 2860ATRA induced Reactive Hemophagocytosis: A Case Report: 197 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3550PDF: 1572HTML: 80 -
-
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
938PDF: 458HTML: 117 -
FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia
7323PDF: 549HTML: 230 -
IMMUNOLOGY OF TUBERCULOSIS
5295PDF: 2002HTML: 7319Untitled: 195 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2180PDF: 817HTML: 952Untitled: 268 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1243PDF: 473HTML: 18570Figure 1: 169Figure 2: 150Figure 3: 167Figure 4: 205Figure 5: 176 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2545PDF: 1131HTML: 141 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1301HTML: 307PDF: 933Suppl. Files: 446







